Protein Kinase B Promotes Radiation-Induced Regulatory T Cell Survival in Bladder Carcinoma

Scandinavian Journal of Immunology

Volumn 76, Issue 1, 2012, Pages 70-74

  Wang, M ^a   Gou, X ^a   Wang, L ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER INFILTRATION; CANCER RADIOTHERAPY; CANCER SURGERY; CELL SURVIVAL; CLINICAL ARTICLE; CYTOMETRY; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IN VITRO STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; THERAPY EFFECT;

AGED; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CARCINOMA, TRANSITIONAL CELL; CELL SURVIVAL; FEMALE; FLOW CYTOMETRY; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-AKT; T-LYMPHOCYTES, REGULATORY; URINARY BLADDER NEOPLASMS;

EID: 84862269381     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2012.02707.x     Document Type: Article

References (16)

1. Watts KL, Ristau BT, Yamase HT, Taylor JA III. Prognostic implications of lymph node involvement in bladder cancer: are we understaging using current methods? BJU Int 2011;108:484-92.
2. Dighe MK, Bhargava P, Wright J. Urinary Bladder Masses: techniques, Imaging Spectrum, and Staging. J Comput Assist Tomogr 2011;35:411-24.
3. Gakis G, Todenhofer T, Stenzl A. The prognostic value of hematological and systemic inflammatory disorders in invasive bladder cancer. Curr Opin Urol 2011;21:428-33.
4. Campbell DJ, Ziegler SF. FOXP3 modifies the phenotypic and functional properties of regulatory T cells. Nat Rev Immunol 2007;7:305-10.
5. Malek TR, Bayer AL. Tolerance, not immunity, crucially depends on IL-2. Nat Rev Immunol 2004;4:665-74.
6. Mellor AL, Munn DH. Physiologic Control of the Functional Status of Foxp3+ Regulatory T Cells. J Immunol 2011;186:4535-40.
7. Kozawa E, Sugiura H, Wasa J et al. Suppression of Tumour Metastasis in a Murine Osteosarcoma Model with Anti-CD25 Monoclonal Antibody Treatment. Anticancer Res 2010;30:5019-22.
8. Hers I, Vincent EE, Tavare JM. Akt signalling in health and disease. Cell Signal 2011;23:1515-27.
9. Freudlsperger C, Burnett JR, Friedman JA, Kannabiran VR, Chen Z, Van Waes C. EGFR-PI3K-AKT-mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapy. Expert Opin Ther Targets 2010;15:63-74.
10. Shimura T, Kakuda S, Ochiai Y et al. Acquired radioresistance of human tumor cells by DNA-PK/AKT/GSK3[beta]-mediated cyclin D1 overexpression. Oncogene 2010;29:4826-37.
11. Kayser G, Schulte-Uentrop L, Sienel W et al. Stromal CD4/CD25 positive T-cells are a strong and independent prognostic factor in non-small cell lung cancer patients, especially with adenocarcinomas. Lung Cancer. 2012. January 31. [Epub ahead of print].
12. Boorjian SA, Sheinin Y, Crispen PL et al. T-cell coregulatory molecule expression in urothelial cell carcinoma: clinicopathologic correlations and association with survival. Clin Cancer Res 2008;14:4800-8.
13. Yang SB, Du Y, Wu BY et al. Integrin alphavbeta6 promotes tumor tolerance in colorectal cancer. Cancer Immunol Immunother 2012;61:335-42.
14. Gao Y, Ishiyama H, Sun M et al. The alkylphospholipid, perifosine, radiosensitizes prostate cancer cells both in vitro and in vivo. Radiat Oncol 2011;6:39.
15. Nijkamp MM, Hoogsteen IJ, Span PN et al. Spatial relationship of phosphorylated epidermal growth factor receptor and activated AKT in head and neck squamous cell carcinoma. Radiother Oncol 2011;101:165-70.
16. Yang HJ, Youn H, Seong KM et al. Psoralidin, a dual inhibitor of COX-2 and 5-LOX, regulates ionizing radiation (IR)-induced pulmonary inflammation. Biochem Pharmacol 2011;82:524-34.